ANIK 8-K: Guidance raise

Anika Therapeutics

Filed with the SEC on · accession 0001171843-26-007211

ANIK filed a 8-K (current report) with the SEC on Nov 6, 2026. Anika Therapeutics reported Q3 2026 revenue of $30.6 million, up 10% year over year, and raised the lower end of its full-year 2026 revenue guidance and its 2026 adjusted EBITDA guidance.

Summary of the filing

Anika Therapeutics reported Q3 2026 revenue of $30.6 million, up 10% year over year, and raised the lower end of its full-year 2026 revenue guidance and its 2026 adjusted EBITDA guidance. The company also disclosed that the FDA issued a not-approvable letter for its Hyalofast PMA application.

Key details

Q3 2026 total revenue$30.6M
Q3 2025 total revenue$27.8M
Q3 2026 Commercial Channel revenue$14.0M
Q3 2026 OEM Channel revenue$16.6M
Integrity trailing 12-month revenue$7.5M
Expected total payments from new Hyvisc partnership$8.0M
Upfront payment expected in Q1 2027 from Hyvisc partnership$4.0M
IssuerAnika Therapeutics, Inc.
Distribution partner for hyviscBoehringer Ingelheim
Oem customerJ&J DePuy Synthes
President and chief executive officerSteve Griffin

✦ Ask GOAX AI about this filing — what it means for ANIK, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ANIK?

Click here

Frequently asked questions

What did ANIK file with the SEC on Nov 6, 2026?

ANIK filed a 8-K (Guidance raise). Anika Therapeutics reported Q3 2026 revenue of $30.6 million, up 10% year over year, and raised the lower end of its full-year 2026 revenue guidance and its 2026 adjusted EBITDA guidance. The company also disclosed that the FDA issued a not-approvable letter for its Hyalofast PMA application.

What does a guidance raise mean for ANIK stock?

Guidance is the company’s own forecast. Investors price stocks on the future, so a raise or cut often moves the stock more than the past quarter’s numbers.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other ANIK SEC filings

Get alerts when ANIK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days